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Abstract
Inflammation is part of a complex biological response of vascular tissue to pathogens or damaged cells. First inflammatory
cells attempt to remove the injurious stimuli and this is followed by a healing process mediated principally by phagocytosis
of senescent cells. Hypoxia and p38-MAPK are associated with inflammation, and hypoxia inducible factor 1 (HIF-1) has been
detected in inflamed tissues. We aimed to analyse the role of p38-MAPK and HIF-1 in the transcriptional regulation of CD36,
a class B scavenger receptor, and its ligand thrombospondin (TSP-1) in macrophages and to evaluate the involvement of
this pathway in phagocytosis of apoptotic neutrophils. We have also assessed HIF-1a, p38-MAPK and CD36 immunostaining
in the mucosa of patients with inflammatory bowel disease. Results show that hypoxia increases neutrophil phagocytosis by
macrophages and induces the expression of CD36 and TSP-1. Addition of a p38-MAPK inhibitor significantly reduced the
increase in CD36 and TSP-1 expression provoked by hypoxia and decreased HIF-1a stabilization in macrophages. Transient
transfection of macrophages with a miHIF-1a-targeting vector blocked the increase in mRNA expression of CD36 and TSP-1
during hypoxia and reduced phagocytosis, thus highlighting a role for the transcriptional activity of HIF-1. CD36 and TSP-1
were necessary for the phagocytosis of neutrophils induced by hypoxic macrophages, since functional blockade of these
proteins undermined this process. Immunohistochemical studies revealed CD36, HIF-1a and p38-MAPK expression in the
mucosa of patients with inflammatory bowel disease. A positive and significant correlation between HIF-1a and CD36
expression and CD36 and p38-MAPK expression was observed in cells of the lamina propria of the damaged mucosa. Our
results demonstrate a HIF-1-dependent up-regulation of CD36 and TSP-1 that mediates the increased phagocytosis of
neutrophils by macrophages during hypoxia. Moreover, they suggest that CD36 expression in the damaged mucosa of
patients with inflammatory bowel disease depends on p38-MAPK and HIF-1 activity.
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Introduction
Inflammation is part of the complex biological response of
vascular tissues to harmful stimuli such as pathogens or damaged
cells, by which the injurious stimuli should be removed and the
healing process initiated. Hypoxia and p38 group mitogen-
activated protein kinase (p38-MAPK) have been associated with
inflammatory diseases [1–3]. Hypoxia inducible factor-1 (HIF-1) is
the main regulator of the transcriptional response to hypoxia and
its activity is modulated by the p38-MAPK signaling pathway
[4,5]. Stabilized HIF-1a is observed in several inflamed tissues
and, in the case of clinical colitis it has been detected in epithelial
and inflammatory cells [6–8]. In epithelial cells HIF-1 induces the
expression of genes involved in mucosal defence and repair, such
as mucin 3 and trefoil factors [9,10], and has been identified as
a critical factor for barrier protection. The role it plays in
inflammatory cells seems to be more complex, with specific
functions being reported according to the type of cell. HIF-1
increases the expression of ß2 integrin, which promotes neutrophil
binding to the endothelium [11,12], and activation of HIF has
been reported during macrophage differentiation [13]. At the
inflammatory focus, HIF-1 prevents the apoptosis of neutrophils
and mediated bacterial phagocytosis by macrophages [12,14–16].
Considered as a whole, these observations demonstrate a protective
effect of HIF-1 in epithelial cells and point to a key role in the
activation of the innate immune response against pathogens and
injury. However, the involvement of HIF-1 and its transcriptional
activity in the clearance of cellular debris and apoptotic cells
mediated by macrophages [17], a crucial process in the resolution
of inflammation, is yet to be clarified.
CD36 is a heavily glycosylated transmembrane protein belong-
ing to an evolutionarily conserved family of scavenger receptors.
This multifunctional receptor is expressed on the surface of
different cells, including macrophages, and is known to be involved
in scavenger recognition of apoptotic cells [18,19], exogenous
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pathogens and their inflammatory compounds [20]. The in-
teraction between CD36 and apoptotic cells seems to be mediated
specifically by thrombospondin-1 (TSP-1), an extracellular matrix
glycoprotein that bridges apoptotic cells, CD36 and the vitronectin
receptor, thus creating a phagocytically active ternary complex
[21]. CD36 expression is transcriptionally controlled by the
nuclear receptor PPARc [22]. However, a recent study has
demonstrated that inflammatory macrophages, in which activation
of PPARc is down-regulated, are endowed with an alternative
mechanism of CD36 expression [23]. Given that HIF-1 has been
related to CD36 expression in vascular and smooth muscle cells
[24] but that little is known about the regulation of CD36 and
TSP-1 in hypoxic macrophages, we set out to analyse the role of
HIF-1 and its transcriptional activity in phagocytosis of neutro-
phils. Our results show a HIF-1 dependent induction of CD36 and
TSP-1 in macrophages which regulates hypoxia-induced phago-
cytosis of apoptotic neutrophils. They also suggest that CD36
regulation by HIF-1is implicated in the damaged mucosa of
patients with inflammatory bowel disease.
Materials and Methods
Ethics Statements
All protocols were approved by the Ethics Committee of the
Faculty of Medicine, University of Valencia. The experiments
performed with human samples were approved by the Institutional
Review Board of Manises’ Hospital (Valencia). Written informed
consent was obtained from all patients.
Cell Culture and Treatment
Human monocytes (U937 and THP1, European Collection of
Cell Culture Salisbury, UK) were cultured in RPMI medium
(Sigma Chemical CO, St. Louis, MO) with 10% inactivated
bovine fetal serum (FBS, Lonza, Basel, Switzerland), 1.1 mg/ml
sodium pyruvate, 100 U/ml penicillin and 100 mg/ml streptomy-
cin. In both cases monocytes were differentiated into macrophages
by culturing them in the presence of phorbol 12-myristate 13-
acetate (PMA, Sigma Chemical, St. Louis, MO [25]) for 48 h.
Some cells were pre-treated with a p38-MAPK inhibitor
(10 mM SB 202190, 24 h; Sigma Chemical, St. Louis, MO). In
other experiments the following functional antibodies were
employed: polyclonal antibody against CD36 (0.2 mg/ml, 3 h,
Santa Cruz Biotechnology, CA, USA); monoclonal antibody
against TSP-1 (0.2 mg/ml, 3 h; Santa Cruz Biotechnology),
horseradish peroxidase-conjugated goat anti-mouse IgG (0.2 mg/
ml; 3 h; Pierce, Rockford, IL USA); or goat anti-rabbit IgG
(0.2 mg/ml; 3 h, Pierce).
Human peripheral blood mononuclear cells (PBMC) were
isolated from healthy donors by Ficoll density gradient centrifu-
gation. Monocytes were plated in 12-well tissue culture plates and
matured to macrophages by culturing in X-Vivo 15 medium
(BioWhittaker) supplemented with 1% human serum and 20 ng/
nl recombinant human M-CSF (Peprotech, France) at 37uC in 5%
CO2 for 6 days.
Hypoxia (3% O2) was established by incubating the cells for 5 h
in a CO2/O2 incubator (model INVIVO2 400, RUSKINN
Technology Ltd, Pencoed, UK) with a blend of 5% CO2 and the
desired percentage of O2 and N2 up to a total of 100%. Normoxic
controls were obtained by incubating the cells at 21% O2.
RNA interference. U937 cells were transfected with a vector-
targeting human HIF-1a (miHIF-1a) or a non-targeting control
vector (mock), as described previously [26]. Lipofectamine-2000
(Invitrogen Life Technologies, Barcelona, Spain) was employed as
a transfection reagent and used according to the manufacturer’s
instructions. Twenty-four hours after transfection the cells were
incubated for 5 h in normoxic or hypoxic conditions, as described
above.
Neutrophil isolation, apoptosis and staining. Human
peripheral blood polymorphonuclear (PMN) cells were isolated
from whole blood of healthy volunteers using sodium citrate as
an anticoagulant [27]. Samples were incubated with dextran
(3%) for 45 min. PMN cells in the supernatant were separated
by gradient density centrifugation (250 g, 25 min) with Ficoll-
PaqueTM Plus. Following red blood cell lysis, neutrophils were
washed (HBSS without Ca2+ or Mg2+) and re-suspended in
complete RPMI medium. To induce spontaneous apoptosis,
neutrophils were cultured at 37uC for 24 h (56106 cells/ml in
cultured medium without serum in a humidified atmosphere
containing 5% CO2). Purity of isolation and apoptosis of
neutrophils were assessed by Wright’s Giemsa staining. Neutro-
phil preparations with more than 90% apoptotic cells were
labeled with 5-(and-6)-carboxy fluoresceindiacetatesuccinimidyl
ester (CFSE) (Invitrogen Life Technologies, Barcelona, Spain)
following the manufacturer’s instructions. Labelled cells were
used as targets in the phagocytosis assay.
Phagocytosis assay. Following a 4 h-period of normoxic or
hypoxic conditions, macrophages were co-cultured with CFSE-
labeled apoptotic neutrophils at a phagocyte-to-target ratio of
1:10. One hour later, cells were washed thoroughly with PBS.
U937 cells were stained with Hoechst 33342 (Sigma-Aldrich,
Steinheim, Germany) in order to visualize the nuclei and with
a fluorescent mitochondrion-selective probe (MitoTrackerH Red
580, Invitrogen Life Technologies, Barcelona, Spain) in order to
define the cytoplasm area, and were then fixed with para-
formaldehyde 4% for 10 min. Samples were analyzed with
a fluorescent microscope (IX81, Olympus, Hamburg, Germany)
and the CFSE fluorescent signal was quantified using the static
cytometer software ‘Scan’ version 2.03.2 (Olympus, Hamburg,
Germany). This system automatically counts the total number of
cell nuclei per field and the number of phagocytic cells (green
fluorescence on red fluorescence). All treatments were performed
in duplicate in 12-well plates, and 20 images per well (around 2000
cells) were recorded. Results are expressed as intensity of
fluorescence in arbitrary units.
Protein extraction and western blot analysis of HIF-1a,
CD36 and TSP-1 expression. U937cells (2.5?106 cells) were
suspended and incubated on ice for 15 min with 50 ml of lysis
buffer (10 mM HEPES, pH 7.5, 2 mM MgCl2, 1 mM EDTA,
1 mM EGTA, 10 mM NaCl, 1 mM DTT, 10 mM NaF,
0.1 mM Na3VO4, 0.2% NP40, 1 mM Pefabloc SC (AEBSF)
(Roche Diagnostics GmbH, Mannheim, Germany), supplemen-
ted with Protease Inhibitor Cocktail (Roche Diagnostics GmbH,
Mannheim, Germany). Lysates were centrifuged for 10 min at
4uC (16000 g). Supernatants were considered cytosolic extracts.
Pellets were sonicated for 10 min in 50 ml nuclear extraction
buffer (25 mM HEPES, pH7.5, 500 mM NaCl, 1 mM DTT,
10 mM NaF, 10% Glycerol, 0,2% NP40, 5 mM MgCl2, 1 mM
Pefabloc SC (Roche Diagnostics GmbH, Mannheim, Germany)
supplemented with Protease Inhibitor Cocktail (Roche Diag-
nostics GmbH, Mannheim, Germany). Nuclear lysates were
centrifuged for 10 min at 4uC (16000 g). Supernatants were
considered nuclear extracts. Total protein concentration in
lysates was quantified using the Pierce BCA protein assay kit
(Pierce, Rockford, IL USA). Equal amounts of protein were
loaded onto SDS/PAGE gels and analyzed by Western blot, as
described previously [10]. TSP-1 gels were run in non-reducing
conditions. Membranes were blocked with 5% non-fat dry milk
in TBS-T (20 mM Tris/HCl pH 7.2, 150 mM NaCl and 0.1%
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Tween 20) and incubated overnight with a monoclonal antibody
against human HIF-1a (dilution 1:250; BD Biosciences, San
Jose, CA), human TSP-1 (dilution 1:300; Thermo Scientific,
Runcorn, Cheshire WA7 1PR, UK), human CD36 (1:250;
Abcam, Cambridge, UK) or Actin (dilution 1:10000; Sigma-
Aldrich, MO, USA). Protein bands were detected by LAS-3000
(Fujifilm) during incubation with horseradish peroxidase-conju-
gated goat anti-mouse IgG (dilution 1:2500; Pierce, Rockford,
IL USA) or goat anti-rabbit IgG (1:5000; Pierce, Rockford, IL
USA) following treatment with supersignal west picochemilumi-
nescent substrate (Pierce, Rockford, IL USA). Protein expression
was quantified by means of densitometry using Image Gauge
Version 4.0 software (Fujifilm Global, Barcelona, Spain). Data
were normalized to actin and results are expressed as fold
induction vs control group.
RNA Extraction and PCR Analysis
Total RNA was isolated from U937cells using the RNeasy Mini
kit (Qiagen, Valencia, CA, USA). cDNA was synthesised and real-
time PCR was performed as described previously [26]. Specific
oligonucleotides for HIF-1a (59-GAAAGCGCA AGTCCT-
CAAAG-39 and 59-TGGGTAGGAGATGGAGATGC-39),
TSP-1 (59-AGAGAACAGAGCCCCAC AGA-39 and 59-
CCCAAAATATCCTGGGAGGT-39), and CD36 (59-CAGTTG-
GAGACCTGCTTATCC-39 and 59-GCGTCC TGGGTTA-
CATTTTC-39) were designed according to reported sequences.
Actin (59-GGAC TTCGAGCAAGAGATGG-39 and 59-
CTGTACGCCAACACAGTGCT-3`) expression was used as an
internal control. The threshold cycle (CT) was determined and
relative gene expression was expressed as follows: change in
expression (fold) = 22D(DCT
) where DCT=CT (target) - CT
(housekeeping), and D(DCT) =DCT (treated) - DCT (control).
Static Cytometry
PBMC and U937-derived macrophages were exposed to
hypoxia for 5 h. After treatment, cells were fixed with 2%
paraformaldehyde, permeabilized with 0.1% Triton-X100, and
then stained with polyclonal antibody against CD36 (1:200, Santa
Cruz Biotechnology, Santa Cruz, CA). FITC or TexRed labeled
goat anti-rabbit IgG (H + L) (1:200, Abcam, Cambridge, UK)
were used as the secondary antibody, and 1 mM Hoechst 33342
(Sigma-Aldrich, Steinheim, Germany) was added to stain nuclei.
Fluorescence (18 images per well) was visualized using the
fluorescence microscope and the fluorescent signal was quantified
using the static cytometer software ‘Scan’ version 2.03.2.
Chromatin Immunoprecipitation
U937 cells were differentiated to macrophages. Following the
hypoxia/normoxia treatment for 5 h, cells were washed twice with
PBS and cross-linked with 1% formaldehyde at room temperature
for 10 min. Cells then were rinsed with ice-cold PBS twice and
collected into 100 mM Tris-HCl (pH 9.4), 10 mM DTT and
incubated for 15 min at 30uC and centrifuged for 5 min at 2000 g.
Cells were washed sequentially with 1 ml of ice-cold PBS, buffer I
(0.25% Triton X-100, 10 mM EDTA, 0.5 mM EGTA, 10 mM
HEPES, pH 6.5), and buffer II (200 mM NaCl, 1 mM EDTA,
0.5 mM EGTA, 10 mM HEPES, pH 6.5). Cells were then
resuspended in 0.3 ml of lysis buffer (1% SDS, 10 mM EDTA,
50 mM Tris-HCl, pH 8.1, 16 protease inhibitor cocktail (Roche
Diagnostics GmbH, Mannheim, Germany) and sonicated three
times for 10 s each at the maximum setting (Branson, Digital
Sonifier) followed by centrifugation for 10 min. Supernatants were
collected and diluted in buffer (1% Triton X-100, 2 mM EDTA,
150 mM NaCl, 20 mM Tris-HCl, pH 8) followed by immuno-
clearing with 2 mg sheared salmon sperm DNA, 20ml pre-immune
serum and protein A-sepharose (45 ml of 50% slurry in 10 mM
Tris-HCl, pH 8, 1 mM EDTA) for 2 h at 4uC. Immunoprecip-
itation was performed overnight at 4uC with anti-HIF1a antibody
(Novus Biologicals, CO, USA), or with control IgG antibody
(Pierce). After immunoprecipitation, 45 ml protein A-Sepharose
and 2 mg of salmon sperm DNA were added and the incubation
continued for 1 h. Precipitates were washed sequentially for
10 min each in TSE I (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris-HCl, pH 8, 150 mM NaCl), TSE II (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8,
500 mM NaCl), and buffer III (250 mMLiCl, 1% NP-40, 1%
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8). Precipi-
tates were then washed three times with TE buffer and extracted
three times with 1% SDS, 100 mM NaHCO3. Eluates were
pooled and heated at 65uC for at least 6 h to reverse the
formaldehyde cross-linking. DNA fragments were purified with
a Montage PCR Kit (Millipore, Germany). PCR was performed
using PCR Master (Roche Diagnostics GmbH, Mannheim,
Germany) with the following primers: 59-AGATCTTTCGT-
TAAACCCCTGGTCCG-39 and 59-CTCGAGT-
CATGTCCTTTCTCACGTCCA-39, detecting the region 233
to2493 in TSP-1 promoter (35 cycles). The PCR products were
separated by electrophoresis in 2% agarose gel.
Electrophoretic Mobility Shift Assay
Nuclear extracts from miHIF1a or mock-transfected and non-
transfected U937 cells were obtained as described above.
Synthetic oligonucleotides (biotin-labelled) were synthesized
(TIB MOLBIOL GmbH Berlin, Germany) and used as probes
in electrophoretic mobility shift assays (EMSAs). Analysis
revealed what appeared to be a hypoxic response element
(HRE) motif (-62 TCA CAA TCT GGA CGT GAG AAA
GGA CAT-35) in the TSP-1 promoter. A mutated probe-
binding site (TSP-1 mt: TCA CAA TCT GGA AAA AAG
AAA GGA CAT) or excess unlabelled probes (XS) were used as
controls. Nuclear extracts (10mg) were incubated for 5 min with
or without an excess unlabelled probe in DNA binding buffer
(Pierce) supplemented with 5 mM MgCl2, 50 ng/ml poly-d[I-C]
(Pierce), 0.05% NP40 (Pierce) and 2.5% glycerol at room
temperature. The labelled probe (25 fmol) was then added to
the reaction mixture and incubated for 30 min at room
temperature in a final volume of 20 ml. DNA-protein was
resolved in a 6% non-denaturing polyacrylamide gel, as
described previously. DNA-protein complexes were transblotted
to BiodyneH B nylon membrane (Pierce, Rockford, IL USA),
probed with streptavidin-horseradish peroxidase conjugate
(Pierce, Rockford, IL USA) and developed by enhanced
chemiluminescence.
Immunohistochemical Studies
Patients clinically diagnosed with typical Crohn’s disease and
ulcerative colitis underwent a colonoscopy or sigmoidoscopy
during which biopsy specimens were taken, from damaged and
non-damaged mucosa (Table 1). HIF-1a, p38-MAPK and
CD36 immunostaining was performed in representative 5 mm
sections of paraffin-embedded tissues. Antigen retrieval was
carried out with a-chymotrypsin for HIF-1a antibody (37uC,
20 min) or sodium citrate buffer pH=9 for CD36 and p38-
MAPK antibody (100uC, 20 min). In all cases, endogenous
peroxidase activity was suppressed by immersion in 0.3%
hydrogen peroxide (15 min). Following blocking with 5% horse
serum, sections were incubated overnight (4uC) with a macro-
phage marker antibody (Vector Laboratories, Peterborough,
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UK) or a mouse monoclonal antibody against HIF-1a (Novus
Biologicals, CO, USA, 1:60), CD36 (1:100) or p38-MAPK
phosphorylated at Tyr182 (Novus Biologicals, CO, USA, 1:200).
A horse anti-mouse/rabbit biotinylated antibody (Vector Lab-
oratories, Peterborough, UKr, 1:200) was employed as a sec-
ondary antibody. The VECTASTAIN elite ABC system Kit
(Vector Laboratories, Peterborough, UK) was used to develop.
All tissues were counterstained with hematoxylin and the
specificity of the immunostaining was confirmed by the absence
of staining in analogous tissue sections when the primary or
secondary antibodies were omitted. An area of 0.135 mm2 was
analyzed for quantitative analysis.
Statistical Analysis
Data are expressed as mean 6 s.e.m. and were compared by
analysis of variance (one way-ANOVA) with a Newman-Keuls
post hoc correction for multiple comparisons or a t-test when
appropriate. A P value,0.05 was considered to be statistically
significant. The correlation between CD36 and HIF-1 or CD36
and p38-MAPK was analyzed using the Spearman’s correlation
coefficient.
Results
Hypoxia Increases the Phagocytosis of Apoptotic
Neutrophils by Macrophages
Phagocytosis of CFSE-labelled apoptotic neutrophils was
analyzed by static cytometry. As shown in Fig. 1, hypoxia
enhanced the phagocytic activity (analyzed as intensity fluores-
cence in the assay) of both U937 and THP1 macrophages
compared with normoxia. Western blotting revealed that in-
cubation of U937 and THP1 macrophages in hypoxic conditions
(3% O2) induced HIF-1a stabilization.
Hypoxia Induces the Expression of CD36 and TSP-1 and
HIF-1a Stabilization through a p38-MAPK-dependent
Mechanism
CD36 protein expression was detected in control U937cells
(Fig. 2). Hypoxia induced a slight but significant increase in CD36
protein expression compared with normoxia as analyzed by
western blot. This increase was confirmed by fluorescence static
cytometry in both U937 cells and primary macrophages obtained
from buffy coat (Figure S1). In a similar manner, TSP-1 protein
expression was detected in control U937cells and hypoxia induced
a significant increase in its expression compared with normoxia
(Fig. 2).
The role of the p38-MAPK pathway in the effects of hypoxia on
CD36 and TSP-1 expression and HIF-1a stabilization was studied
by applying SB 202190, a p38-MAPK inhibitor. As shown in
Fig. 2, treatment of cells with SB 202190 significantly decreased
the protein expression of CD36 and TSP-1 induced by hypoxia,
while it did not significantly modify levels of either protein in
normoxia. This drug significantly undermined the stabilization of
HIF-1a induced by hypoxia (Fig. 2).
HIF-1 Mediates Phagocytosis and the Induction of CD36
and TSP-1 Induced by Hypoxia
Expression of HIF-1a in U937 macrophages was knocked down
with miRNA as previously described [26]. HIF-1a protein levels in
hypoxia were significantly lower in cells expressing miHIF-1a than
in mock cells (Fig. 3A). CD36 and TSP-1 mRNA expression was
detected in control U937cells in normoxia and it was increased by
hypoxia (Fig. 3A). The hypoxia-induced increase in the expression
of CD36 and TSP-1 proteins and mRNA was abolished in cells
treated with miHIF-1a, thus confirming the involvement of HIF-1
in the up-regulation of these genes during hypoxia. Phagocytosis of
CFSE-labelled apoptotic neutrophils was analyzed in miHIF-1a
and mock macrophages. As shown in Fig. 3B, hypoxia enhanced
the phagocytic activity of mock macrophages compared with
normoxia, but it failed to do so in miHIF-1a cells.
HIF-1 Binds to the Promoter Region of TSP-1
Analysis of the TSP-1 gene promoter identified some HIF-1
binding sites (HRE sequence) between positions 2493 and 233
relative to the transcription starting site. To examine the potential
role of HIF-1a on the expression of TSP-1, ChIP assays were
performed with an affinity-purified antibody directed against HIF-
1a (Fig. 4A). DNA was extracted from the input, bound (anti-
HIF1a), and unrelated (anti-IgG) antibody fractions; equal
amounts from each fraction were amplified using primers specific
for the TSP-1 promoter region. The binding was determined by
the relative intensity of ethidium bromide fluorescence compared
with the input control. Our data show HIF-1a binding to the TSP-
1 gene in hypoxia. Afterwards we employed EMSA to examine the
binding of HIF-1 to the HRE consensus between positions 262
and 235 relative to the transcription starting site, in the TSP-1
promoter. Hypoxia increased the binding of HIF-1 to its consensus
sequence in the TSP-1 promoter in both non-transfected and
control mock-transfected cells (Fig. 4B). The specificity of the assay
was confirmed by the fact that binding was diminished when cells
were transfected with miHIF1a (lane 6), when a mutated promoter
was used (lane 5) or with an excess of unlabelled probe (XS, lane
4). Collectively, these results indicate that hypoxia elicits nuclear
accumulation of HIF-1a, which binds to the consensus HRE
located within the TSP-1 promoter.
Table 1. Patient clinical information.
Ulcerative colitis Crohn’s disease
Number of patients 10 4
Age
17–40 years 3 1













5 ASA 9 –
AZA 1 3
Anti TNF 1 1
doi:10.1371/journal.pone.0048535.t001
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CD36 and TSP-1 Mediate Phagocytosis Induced by
Hypoxia
Specific functional antibodies were employed to block the
activity of CD36 and TSP-1 in U937 and THP1 cells and thus
evaluate the role of these molecules in phagocytosis. While
hypoxia induced a significant increase in phagocytosis in IgG
control cells, it failed to do so in cells treated with a monoclonal
antibody against CD36. This antibody did not significantly modify
phagocytosis in normoxia (Fig. 5). In a similar manner, a TSP-1
antibody significantly reduced the increase in phagocytosis in-
duced by hypoxia (Fig. 5). In neither case did functional blockade
of TSP-1 significantly modify phagocytosis in normoxic condi-
tions.
CD36 Expression Correlates with HIF-1 and p38-MAPK
Expression in the Damaged Mucosa of Patients with IBD
In order to analyze the relevance of CD36 expression by HIF-1
in inflammation, we performed immunohistochemical studies of
the damaged and non-damaged mucosa of patients with in-
flammatory bowel disease. As can be seen in Fig. 6A, cells of the
lamina propria of the non-damaged mucosa, morphologically
identified as macrophages, exhibited CD36 expression. The
number of CD36-positive cells was significantly lower in the
damaged mucosa than in non-damaged mucosa (Fig. 6B). The
analysis of HIF-1a stabilization revealed a very low expression of
this transcription factor in the lamina propria of non-damaged
mucosa and an increased expression in the damaged mucosa
(Fig. 6A, B). Evaluation of p38-MAPK immunostaining showed
that this enzyme was widely expressed in non-damaged mucosa
and the signal was increased in damaged mucosa (Fig. 6A, B).
A detailed analysis of the immunostaining in the damaged
mucosa of patients with IBD showed a positive and significant
correlation between HIF-1a and CD36-positive cells (R Spear-
man= 0.7170, P= 0.0087**, n = 12). In contrast, no significant
correlation was observed between CD36 and HIF-1a immunos-
taining in non-damaged mucosa (R Spearman=20.0513,
P= 0.95, n= 5) (Fig. 6C). Interestingly, a significant correlation
was also observed in the damaged mucosa between p38-MAPK
and CD36 (R Spearman= 0.6525, P= 0.0215*, n= 12) while no
significant correlation was observed in the non-damaged mucosa
(R Spearman= 0.5204, P= 0.2311, n = 7) (Fig. 6C).
Discussion
The findings of the present study demonstrate that HIF-1
transcriptional regulation plays an important role in hypoxia-
induced phagocytosis of apoptotic neutrophils mediated by
macrophages.
Phagocytosis by macrophages is critical for the uptake and
degradation of infectious agents and senescent cells, a process
implicated in development, tissue remodeling, the immune
response and inflammation [28]. The present results show that
exposure of human macrophages to hypoxia leads to an increase
Figure 1. Hypoxia increases phagocytosis of apoptotic neutrophils by human macrophages. Representative images show phagocytosis
of apoptotic neutrophils by U937 or THP1 cells in normoxia and hypoxia. In all cases blue staining identifies the nuclei, red staining defines the
cytoplasm of the cells, and green staining indicates neutrophils. This system automatically counts the total number of cell nuclei per field and the
number of cells exhibiting green fluorescence on red fluorescence (phagocytic cells). Inserts show magnification of the image. Results are expressed
as intensity of fluorescence in arbitrary units. Bars in the graphs represent mean6 SEM (n.3). Groups were compared using t-test analysis. Significant
difference from the respective group in normoxic conditions is shown by *P,0.05. Western blot showing HIF-1a stabilization induced by hypoxia in
U937 or THP1 cells.
doi:10.1371/journal.pone.0048535.g001
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in the rate of phagocytosis of apoptotic neutrophils. Previous
studies have shown an increase in bacterial phagocytosis by
murine macrophages in hypoxia [15,16,29] and we have observed
a similar process in E coli phagocytosis by human macrophages
(data not shown). Considered together, the evidence points to the
existence of a general mechanism that is activated in macrophages
by hypoxia and which leads to an increase in phagocytic activity
irrespective of the particle that is to be recognized and in-
ternalized. By highlighting the induction of neutrophil phagocy-
tosis by low oxygen levels, our data extend the pathophysiological
relevance of hypoxia from the initial stages of the inflammatory
process to the resolution of inflammation.
CD36 in macrophages acts as a class B scavenger receptor
known to recognize, bind with and internalize apoptotic
neutrophils [19,20]. CD36 regulation by hypoxia has been studied
and contradictory results have been reported [13,30]. The present
study, by using different experimental approaches, demonstrates
a slight but significant increase in CD36 expression induced by
hypoxia. In addition we also show an increased up-regulation of
TSP-1 expression by hypoxia in macrophages. It has been report
that CD36 binds to TSP-1 as a pattern recognition receptor, thus
constituting a phagocytically active ternary complex which
mediates the phagocytosis of neutrophils [21]. Hypoxia has been
implicated in the activation of p38-MAPK [31,32], and our
present data reveal a role for this pathway in the hypoxia-induced
expression of CD36 and TSP-1, since pharmacological blockade
of the activity of these enzymes by SB 202190 significantly
decreased their levels. The p38-MAPK signalling pathway is
known to modulate the activity of HIF-1 [4,5] and HIF-1 has been
related to CD36 expression in endothelial vascular and smooth
muscle cells [24]. Interestingly, the present study shows that
inhibition of p38-MAPK significantly undermines the HIF-1a
stabilization induced by hypoxia in macrophages, which suggests
a role for HIF-1 in said expression. In line with this, our results
demonstrate that the transcriptional activity of HIF-1 is involved
in the effects of hypoxia on both CD36 and TSP-1 expression,
since down-regulation of this transcription factor by transient
transfection significantly decreased the mRNA and protein
expression of both molecules. As far as we know, this is the first
report of hypoxia-induced HIF-1-dependent generation of TSP-1
in macrophages. In addition, our results take current evidence one
step further by confirming the binding of HIF-1 to an HRE
sequence in the promoter region of the TSP-1 gene, which
suggests that this gene is a direct target of HIF-1. In light of
a previous study reporting CD36 as a target gene of HIF-1 [24],
the present findings indicate that, in hypoxic macrophages, HIF-1
synchronizes the transcriptional up-regulation of these two genes,
both of which are crucial to the process of phagocytosis.
A previous study by our group showed a correlation between
the expression of HIF-1 in macrophages and the clearance of
infiltrated neutrophils in the mesentery of aspirin-treated rats [33]
which lead us to suggest the involvement of this transcription
factor in phagocytosis of neutrophils. The present study by the
selective diminution of HIF-1a in cultured macrophages demon-
strates a role for HIF-1 in phagocytosis of apoptotic neutrophils. In
addition we have evaluated the relevance of CD36 and TSP-1 up-
regulation by hypoxia in the phagocytic activity of macrophages
using function-specific antibodies. Results show that CD36 is
required for the induction of macrophage-mediated phagocytosis
of apoptotic neutrophils during hypoxia. In a similar manner,
immunological blockade of TSP-1 abolished the increase in
phagocytosis of apoptotic neutrophils induced by hypoxia. This is
in accordance with a putative role for TSP-1 as a bridge between
CD36 and membrane phospholipids of apoptotic cells [21]. Since
Figure 2. Hypoxia induces TSP-1 and CD36 expression and HIF-
1a stabilization through activation of p38-MAPK. U937 cells were
maintained under normoxia or hypoxia in the presence or absence of
SB 202190 (a p38-MAPK inhibitor, 10 mM, 24 h) and levels of proteins
were determined by Western blot. Graphs show quantification of HIF-
1a, TSP-1 and CD36 by densitometry. In hypoxia, cells treated with SB
202190 exhibited significantly lower protein expression of HIF-1a, TSP-1
and CD36 than cells treated with vehicle. In all cases bars represent
mean6 SEM (n.3). Comparisons between groups were performed
using ANOVA followed by a Newman Keuls test. *P,0.05 and
***P,0.001 with respect to all groups in the same graph and
###P,0.001 vs. bars in normoxia.
doi:10.1371/journal.pone.0048535.g002
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Figure 3. HIF-1 mediates phagocytosis and the increased expression of TSP-1 and CD36 induced by hypoxia. A) Western blot showing
HIF-1a stabilization, CD36 and TSP-1 in U937 cells transfected with miHIF-1a and mock-transfected cells (controls). Graphs show quantification of the
HIF-1a, TSP-1 and CD36 proteins by densitometry and mRNA expression of CD36 and TSP-1 by RT-PCR in mock-transfected cells and cells treated with
miHIF-1a. B) Graph shows phagocytosis of apoptotic neutrophils in miHIF-1a or mock-transfected cells. Bars in the graphs represent mean6 SEM
(n.3). Comparisons between groups were performed using ANOVA followed by a Newman Keuls test. *P,0.05 or **P,0.01 with respect to all bars in
the same graph.
doi:10.1371/journal.pone.0048535.g003
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CD36 and TSP-1 need each other to recognize and phagocyte
apoptotic neutrophils, our results reveal that HIF-1 functions by
promoting an effector response by which apoptotic cells are
removed from hypoxic microenvironments. Regulation of these
two genes by HIF-1 could be part of a wider response in which
a subset of genes helps to resolve inflammation.
Finally, we have analyzed the pathophysiological relevance of
CD36 regulation by HIF-1 and p38-MAPK in the intestinal
mucosa of patients with inflammatory bowel disease. Our results
show low HIF-1a stabilization and high CD36 expression in the
non-damaged mucosa which leads us to suggest that transcription
factors other than HIF-1 are involved in the expression of this
scavenger receptor at the healthy mucosa. In this line constitutive
CD36 expression has been shown to be regulated by several
nuclear receptors, including PPARc [22]. Interestingly gene
expression of PPAR-c is down-regulated in the damaged mucosa
of patients with ulcerative colitis [34] which is in accordance with
results in the present study showing a decrease in CD36 expression
in damaged mucosa compared with non-damaged. In contrast to
that observed in the non-damaged mucosa, a detailed analysis of
the damaged mucosa revealed a positive and significant correla-
tion between CD36 and HIF-1a immunostaining. Considering
that HIF-1 is significantly increased in the damaged mucosa our
results propose that at sites of inflammation where the mechanisms
that modulate the constitutive expression of CD36 are down-
regulated, the expression of this scavenger receptor may depend
Figure 4. Recruitment of HIF-1 to the promoter of TSP-1 gene. A) Results show a representative chromatin immunoprecipitation (ChIP)
experiment performed in samples from U937-derived macrophages in normoxia or hypoxia. Chromatin was immunoprecipitated with anti-HIF-1a
antibody, or a non-related antibody anti-IgG as a control. An aliquot of the input chromatin is also shown. Primers specific to the promoter region for
TSP-1 gene were used to amplify the DNA isolated from the ChIP assay. B) HIF-1a expression in nuclear lysates derived from non-transfected cells and
frommiHIF1a or mock-transfected U937cells exposed to normoxia or hypoxia. Interactions between HIF-1a and HRE of the TSP-1 promoter gene were
examined by EMSA using synthetic oligonucleotides and nuclear lysates derived from transfected or non-transfected cells exposed to normoxia or
hypoxia. Specificity was determined with excess unlabelled probed (XS) or mutated probe (n = 3).
doi:10.1371/journal.pone.0048535.g004
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on HIF-1 activity. It is important to note that both down-
regulation of PPAR-c [35] and HIF-1a stabilization have been
related to hypoxia. Taking into account that low oxygen levels are
associated with inflamed tissue results lead us to suggest hypoxia as
an important regulator of CD36 expression at sites of in-
flammation. Reinforcing this observation, both hypoxia and IBD
have been related to p38-MAPK activity [4,5,36–38] and the
present study shows high expression of p38-MAPK in the
damaged mucosa of IBD patients. Positive immunostaining has
been observed in epithelial cells and different cells of the lamina
propria, including macrophages. Despite the high expression, the
quantitative analysis of p38-MAPK immunostaining in cells of the
lamina propria morphologically identified as macrophages shows
a positive and significant correlation with CD36 expression. Taken
together results suggest that CD36 expression at the damaged
mucosa of IBD patients may depend on both p38MAPK and HIF-
1 activity. It is important to note that in some samples we found
a higher number of p38-MAPK positive cells than CD36 positive
cells which suggests that some of the p38-MAPK positive cells are
not expressing CD36. Considering that these cells have been
identified as macrophages it seems likely that in the damaged
mucosa of IBD patients, macrophages with a different pattern of
expression may be present [39]. Further experiments are necessary
to address this question.
Figure 5. Role of CD36 and TSP-1 in phagocytosis mediated by macrophages. Graphs show the effects of CD36 and TSP-1 functional
antibodies or control IgG on phagocytosis of apoptotic neutrophils mediated by U937 cells or THP1 cells. In both cases, blockade of CD36 or TSP-1
significantly reduced hypoxia-induced phagocytosis. Data show the intensity of fluorescence in arbitrary units (quantified by static cytometry). Bars
represent mean6 SEM (n.3). Groups were compared using ANOVA followed by a Newman Keuls test. *P,0.05 shows significant difference with
respect to all groups in the same graph.
doi:10.1371/journal.pone.0048535.g005
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In summary, our findings reveal a mechanism by which the
transcriptional activity of HIF-1 coordinates induction of CD36
and TSP-1 expression in macrophages, a mechanism that
mediates the enhanced phagocytosis of apoptotic neutrophils in
hypoxia. In addition to its known pro-inflammatory action, HIF-1
may also constitute an important regulator in the resolution of
inflammation.
Supporting Information
Figure S1 Hypoxia increases CD36 expression in PBMC
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arbitrary units. Bars in the graphs represent mean6 SEM (n = 3).
Groups were compared using t-test analysis. Significant difference
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